Applicability of a Single Time Point Strategy for the Prediction of Area Under the Concentration Curve of Linezolid in Patients: Superiority of Ctrough- over Cmax-Derived Linear Regression Models

about

Area under the curve predictions of dalbavancin, a new lipoglycopeptide agent, using the end of intravenous infusion concentration data point by regression analyses such as linear, log-linear and power models.

P2860

Q36307070-5F564E10-E998-4D29-8026-574BF554299D

P2860

Applicability of a Single Time Point Strategy for the Prediction of Area Under the Concentration Curve of Linezolid in Patients: Superiority of Ctrough- over Cmax-Derived Linear Regression Models

Item

http://www.wikidata.org/entity/Q36620071

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Applicability of a Single Time ...... rived Linear Regression Models

@ast

Applicability of a Single Time ...... rived Linear Regression Models

@en

type

Item

label

Applicability of a Single Time ...... rived Linear Regression Models

@ast

Applicability of a Single Time ...... rived Linear Regression Models

@en

prefLabel

Applicability of a Single Time ...... rived Linear Regression Models

@ast

Applicability of a Single Time ...... rived Linear Regression Models

@en

P1476

Applicability of a Single Time ...... rived Linear Regression Models

@en

P2093

Muzeeb Syed

http://www.w3.org/2001/XMLSchema#string

Nuggehally R Srinivas

http://www.w3.org/2001/XMLSchema#string

P2860

Differences in the Prediction of Area Under the Curve for a Protease Inhibitor Using Trough Versus Peak Concentration: Assessment Using Published Pharmacokinetic Data for Indinavir.

Prediction of in vivo drug clearance from in vitro data. I: impact of inter-individual variability.

Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections.

Limited sampling strategies for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosis.

Linezolid dosage in pediatric patients based on pharmacokinetics and pharmacodynamics.

Pharmacokinetics, metabolism, and excretion of linezolid following an oral dose of [(14)C]linezolid to healthy human subjects.

Comparative in vitro activities and postantibiotic effects of the oxazolidinone compounds eperezolid (PNU-100592) and linezolid (PNU-100766) versus vancomycin against Staphylococcus aureus, coagulase-negative staphylococci, Enterococcus faecalis, an

Penetration of linezolid into soft tissues of healthy volunteers after single and multiple doses.

Absolute bioavailability and pharmacokinetics of linezolid in hospitalized patients given enteral feedings.

In vitro activities of linezolid against important gram-positive bacterial pathogens including vancomycin-resistant enterococci

P304

69-79

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40268-015-0117-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

289694325

http://www.w3.org/2001/XMLSchema#string

P698

26747454

http://www.w3.org/2001/XMLSchema#string

P932

4767722

http://www.w3.org/2001/XMLSchema#string

Applicability of a Single Time Point Strategy for the Prediction of Area Under the Concentration Curve of Linezolid in Patients: Superiority of Ctrough- over Cmax-Derived Linear Regression Models

about

P2860

P2860

Applicability of a Single Time Point Strategy for the Prediction of Area Under the Concentration Curve of Linezolid in Patients: Superiority of Ctrough- over Cmax-Derived Linear Regression Models

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932